High-resolution metabolomic biomarkers for lung cancer diagnosis and prognosis
Abstract Lung cancer is the leading cause of human cancer mortality due to the lack of early diagnosis technology. The low-dose computed tomography scan (LDCT) is one of the main techniques to screen cancers. However, LDCT still has a risk of radiation exposure and it is not suitable for the general...
Guardado en:
Autores principales: | Shi-ang Qi, Qian Wu, Zhenpu Chen, Wei Zhang, Yongchun Zhou, Kaining Mao, Jia Li, Yuanyuan Li, Jie Chen, Youguang Huang, Yunchao Huang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/522ec738648e412cbed5ee40157a1bd0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Application of Metabolomics to Identify Potential Biomarkers for the Early Diagnosis of Coronary Heart Disease
por: Huali Jiang, et al.
Publicado: (2021) -
Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis
por: Ke Gong MBBS, et al.
Publicado: (2021) -
Serum metabolomics of end-stage renal disease patients with depression: potential biomarkers for diagnosis
por: Dezhi Yuan, et al.
Publicado: (2021) -
Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease.
por: Esther Nkuipou-Kenfack, et al.
Publicado: (2014) -
Diagnosis and prognosis of myocardial infarction on a plasmonic chip
por: Wei Xu, et al.
Publicado: (2020)